Fosbretabulin for the treatment of anaplastic thyroid cancer.

about

Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?

P2860

Q26781365-DDC4634D-BF30-427E-9B6D-6DB92F2D1916

P2860

Fosbretabulin for the treatment of anaplastic thyroid cancer.

Item

http://www.wikidata.org/entity/Q38268163

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Fosbretabulin for the treatment of anaplastic thyroid cancer.

@en

type

Item

label

Fosbretabulin for the treatment of anaplastic thyroid cancer.

@en

prefLabel

Fosbretabulin for the treatment of anaplastic thyroid cancer.

@en

P1476

Fosbretabulin for the treatment of anaplastic thyroid cancer

@en

P2093

Laura D Locati

http://www.w3.org/2001/XMLSchema#string

Lisa Licitra

http://www.w3.org/2001/XMLSchema#string

Roberta Granata

http://www.w3.org/2001/XMLSchema#string

P2860

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug

Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results.

Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow.

A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer.

Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.

A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome

Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling.

Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment.

The interaction with tubulin of a series of stilbenes based on combretastatin A-4.

A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer

P304

2015-2021

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.14.154

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Laura D. Locati

Lisa Licitra

Roberta Granata

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25396774

http://www.w3.org/2001/XMLSchema#string

Fosbretabulin for the treatment of anaplastic thyroid cancer.

about

P2860

P2860

Fosbretabulin for the treatment of anaplastic thyroid cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698